financetom
Business
financetom
/
Business
/
Sonim Technologies Board Approves 1-For-10 Reverse Stock Split; Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sonim Technologies Board Approves 1-For-10 Reverse Stock Split; Shares Fall
Jul 16, 2024 8:33 AM

11:14 AM EDT, 07/16/2024 (MT Newswires) -- Sonim Technologies ( SONM ) said Tuesday its board approved a 1-for-10 reverse split of its common shares, mainly to boost the stock's per-share market price to regain compliance with the Nasdaq Capital Market's minimum-bid price requirement.

The company expects its shares to start trading on a split-adjusted basis, effective Thursday, according to a filing with the US Securities and Exchange Commission.

Sonim ( SONM ) shares were down 3.4% in recent trading.

Price: 0.51, Change: -0.02, Percent Change: -3.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Airlines reaffirms second-quarter profit forecast
United Airlines reaffirms second-quarter profit forecast
May 28, 2024
May 28 (Reuters) - United Airlines Holdings ( UAL ) said on Tuesday the airline continues to expect second-quarter profit to be between $3.75 and $4.25 per share. (Reporting by Kannaki Deka in Bengaluru; Editing by Arun Koyyur) ...
Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License
Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License
May 28, 2024
05:47 PM EDT, 05/28/2024 (MT Newswires) -- Prothena ( PRTA ) said Tuesday it will receive $80 million from Bristol Myers Squibb ( BMY ) after the company exercised its option for the global license to PRX019, an investigational treatment for neurodegenerative diseases. Prothena ( PRTA ) said it is also entitled to receive an additional development, regulatory and sales...
Sight Sciences Trial Results Show Improved Dry Eye Disease Signs, Symptoms for TearCare Patients Crossed Over From Restasis
Sight Sciences Trial Results Show Improved Dry Eye Disease Signs, Symptoms for TearCare Patients Crossed Over From Restasis
May 28, 2024
05:44 PM EDT, 05/28/2024 (MT Newswires) -- Sight Sciences ( SGHT ) said late Tuesday that results from a trial showed that patients treated with a single interventional eyelid procedure enabled by its TearCare technology after receiving Restasis for the first six months saw clinically meaningful improvements in the signs and symptoms of dry eye disease through month 12. Phase...
Betterware de Mexico to Transfer Listing to NYSE
Betterware de Mexico to Transfer Listing to NYSE
May 28, 2024
05:50 PM EDT, 05/28/2024 (MT Newswires) -- Betterware de Mexico (BWMX), a household solutions company based in Mexico, said late Tuesday that it will transfer its common stock listing to the New York Stock Exchange from the Nasdaq Stock Market. The company expects shares to begin trading on NYSE June 7. The common stock will trade under the same symbol...
Copyright 2023-2025 - www.financetom.com All Rights Reserved